Cynosure Group LLC Has $613,000 Holdings in CBIZ, Inc. (NYSE:CBZ)

Cynosure Group LLC decreased its position in CBIZ, Inc. (NYSE:CBZFree Report) by 53.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 7,486 shares of the business services provider’s stock after selling 8,547 shares during the period. Cynosure Group LLC’s holdings in CBIZ were worth $613,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of CBIZ by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 4,716,456 shares of the business services provider’s stock worth $385,948,000 after buying an additional 43,784 shares during the period. State Street Corp boosted its position in CBIZ by 0.9% during the 3rd quarter. State Street Corp now owns 1,130,848 shares of the business services provider’s stock worth $76,095,000 after acquiring an additional 10,555 shares during the period. Geode Capital Management LLC grew its stake in CBIZ by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 1,109,074 shares of the business services provider’s stock valued at $74,644,000 after acquiring an additional 11,615 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of CBIZ by 7.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 704,888 shares of the business services provider’s stock valued at $47,432,000 after purchasing an additional 48,979 shares during the period. Finally, FMR LLC increased its holdings in shares of CBIZ by 27.4% in the 3rd quarter. FMR LLC now owns 594,660 shares of the business services provider’s stock valued at $40,015,000 after purchasing an additional 127,822 shares during the period. 87.44% of the stock is currently owned by hedge funds and other institutional investors.

CBIZ Trading Up 1.5 %

NYSE:CBZ opened at $76.99 on Wednesday. The company has a market capitalization of $4.14 billion, a P/E ratio of 32.62 and a beta of 0.99. The stock’s 50 day moving average price is $79.93 and its 200 day moving average price is $76.97. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.49 and a current ratio of 1.49. CBIZ, Inc. has a 52 week low of $62.66 and a 52 week high of $90.13.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. William Blair reiterated an “outperform” rating on shares of CBIZ in a research note on Thursday, February 27th. StockNews.com downgraded shares of CBIZ from a “hold” rating to a “sell” rating in a research note on Tuesday, February 25th.

Check Out Our Latest Stock Analysis on CBIZ

Insider Transactions at CBIZ

In other CBIZ news, Director Benaree Pratt Wiley sold 6,526 shares of the business’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $71.75, for a total value of $468,240.50. Following the completion of the sale, the director now owns 41,759 shares of the company’s stock, valued at $2,996,208.25. The trade was a 13.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.40% of the stock is currently owned by company insiders.

CBIZ Profile

(Free Report)

CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.

Featured Stories

Want to see what other hedge funds are holding CBZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CBIZ, Inc. (NYSE:CBZFree Report).

Institutional Ownership by Quarter for CBIZ (NYSE:CBZ)

Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.